Refuge Biotech Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Out of Business

  • Employees
  • 16

Employees

  • Latest Deal Type
  • Out of Business

  • Investors
  • 1

Refuge Biotech General Information

Description

Developer of cell therapies intended to fight cancer. The company develops cancer immunotherapy that leverages synthetic biology and gene engineering to unlock the potential of cell therapies to sense their surroundings and conditionally activate or repress multiple genes simultaneously, enabling physicians to get therapies that result in potent and targeted treatments beyond a single target and function to treat cancer.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 1505 Adams Drive
  • Suite D
  • Menlo Park, CA 94025
  • United States
+1 (650)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 1505 Adams Drive
  • Suite D
  • Menlo Park, CA 94025
  • United States
+1 (650)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Refuge Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 03-Aug-2023 Completed Out of Business
4. Debt - PPP 15-Apr-2020 Completed Generating Revenue
3. Early Stage VC (Series B) 02-May-2018 Completed Startup
2. Early Stage VC (Series A) 05-Aug-2016 $8.9M $9.5M Completed Startup
1. Seed Round 30-Oct-2015 $600K $600K Completed Startup
To view Refuge Biotech’s complete valuation and funding history, request access »

Refuge Biotech Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B2
Series B1
Series A2 3,633,084 $0.000010 8% $2.45 $2.45 1x $2.45 19.57%
Series A1 441,420 $0.000010 8% $1.36 $1.36 1x $1.36 2.38%
To view Refuge Biotech’s complete cap table history, request access »

Refuge Biotech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of cell therapies intended to fight cancer. The company develops cancer immunotherapy that leverages synthetic
Drug Discovery
Menlo Park, CA
16 As of 2022

South San Francisco, CA
 

Santa Monica, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Refuge Biotech Competitors (115)

One of Refuge Biotech’s 115 competitors is Senti Bio, a Formerly VC-backed company based in South San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Senti Bio Formerly VC-backed South San Francisco, CA
Kite Pharma Formerly VC-backed Santa Monica, CA
Aro Biotherapeutics Venture Capital-Backed Philadelphia, PA
NexImmune Formerly VC-backed Gaithersburg, MD
Gadeta Formerly VC-backed Utrecht, Netherlands
You’re viewing 5 of 115 competitors. Get the full list »

Refuge Biotech Patents

Refuge Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240100136-A1 Chimeric adaptor proteins and methods of regulating gene expression Pending 05-Mar-2020
US-20190345220-A1 Chimeric proteins and methods of immunotherapy Active 11-Jan-2016
US-20180346543-A1 Chimeric proteins and methods of immunotherapy Active 11-Jan-2016
US-11111287-B2 Chimeric proteins and methods of immunotherapy Active 11-Jan-2016
US-10336807-B2 Chimeric proteins and methods of immunotherapy Active 11-Jan-2016 C07K14/70521
To view Refuge Biotech’s complete patent history, request access »

Refuge Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Refuge Biotech Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
120 Capital Venture Capital Minority
To view Refuge Biotech’s complete investors history, request access »

Refuge Biotech FAQs

  • When was Refuge Biotech founded?

    Refuge Biotech was founded in 2015.

  • Where is Refuge Biotech headquartered?

    Refuge Biotech is headquartered in Menlo Park, CA.

  • What is the size of Refuge Biotech?

    Refuge Biotech has 16 total employees.

  • What industry is Refuge Biotech in?

    Refuge Biotech’s primary industry is Drug Discovery.

  • Is Refuge Biotech a private or public company?

    Refuge Biotech is a Private company.

  • What is Refuge Biotech’s current revenue?

    The current revenue for Refuge Biotech is .

  • How much funding has Refuge Biotech raised over time?

    Refuge Biotech has raised $34.5M.

  • Who are Refuge Biotech’s investors?

    120 Capital has invested in Refuge Biotech.

  • Who are Refuge Biotech’s competitors?

    Senti Bio, Kite Pharma, Aro Biotherapeutics, NexImmune, and Gadeta are some of the 115 competitors of Refuge Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »